On July 1, 2025, Wells Fargo set its price target at $10 for Health Catalyst, Inc. (NASDAQ:HCAT), maintaining a ‘Buy’ rating.

Hess Midstream raised at Wells Fargo, forecasting 15%-17% annual total return from dividends, buybacks and growth plus a ...

HR teams may need to consider this gap to remain competitive in talent acquisition and retention.

Wells Fargo’s asset cap removal, strong earnings, and $40B buyback plan position it for growth and higher returns despite ...

PepsiCo's stock saw a nice bump, climbing 2% after Barclays upgraded its price target from $132 to $144. Trading peaked at $146.40 before settling at $144.56, amidst trading volumes that dipped by 64% ...

Wells Fargo (WFC) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Nonresidential building spending to remain sluggish through 2026, with no turnaround in sight.

Demand is positive: Demand for goods and services remains positive, supported by healthy consumer and business balance sheets ...

The Progressive Corporation (NYSE: PGR) is one of the best long term low volatility stocks to buy now. In a report released ...

Some top executives at Wall Street banks have been showing concern about higher inflation and potential deterioration of the ...

The 12.4% profit gain for the second quarter comes in Wells Fargo & Co.'s first quarterly report since the Federal Reserve ...

The peer-to-peer payment network charges comparatively higher transaction rates, but also offers the potential for new ...